The objective of this observational study is to develop new tools to assess primary Sjögren's syndrome (pSS) symptoms and to measure the severity of eye involvement in these patients.
All clinical trials evaluating the efficacy of immunomodulatory drugs in pSS are negative. This could be due to a lack of sensitivity of the outcome measures used so far to define the response. In this study, investigator will evaluate the feasability, tolerability, and performance of new tools to assess disease evolution: * investigator will develop a webapp to measure the intensity of the symptoms at home on a daily basis (ecological assessment) * investigator will evaluate new ophthalmologic procedures, already used in other conditions but never in pSS, which assess the severity of eye involvement in the disease * investigator will develop an automated method to score the severity of ocular surface lesions in the disease. Patients with a diagnosis of pSS will be included in the study, will undergo detailed ophtalmologic examination, and will then use a webapp, installed on their smartphone, to score their symptoms everyday during 3 months.
Study Type
OBSERVATIONAL
Enrollment
45
A webapp will be installed on the patients' smartphone, which will be used to collect everyday the symptoms of the patients (ESSPRI score)
Evaluation of the mebomian function using the LipiView methodology
CHU de BREST
Brest, France
Variability in the intensity of patient-reported symptoms
Variability over time (day-to-day assessment) of the ESSPRI score (dispersion of the values compared to the mean)
Time frame: 3 months
Tolerability of the daily use of a webapp to measure the symptoms
Score Questionnaire SUS - System Usability Scale. The SUS ranges from 0 to 100, with values above 68 considered as above average.
Time frame: Month 3
Interferometry
Measure of mebomian function using the LipiView technology
Time frame: 3 months
Automated eye surface coloration measurement
Development of an automated method using deep image mining on recorded videos
Time frame: 3 months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.